Trial Profile
Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms HONEST
- Sponsors Daiichi Sankyo Company
- 05 Apr 2016 Results of final analysis published in the Journal of the American College of Cardiology
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
- 04 Feb 2015 Status changed from not yet recruiting to completed, according to University Hospital Medical Information Network - Japan record.